Log in to search using one of your social media accounts:

 

Newly Founded Company, Datum Orthobiologics, to Apply Dental Technology in Orthopedics
Collagen Technology Mimics Nature, to Regenerate Bone and Cartilage NESS ZIONA, Israel, April 24, 2018 -- (Healthcare Sales & Marketing Network) -- Datum Biotech Ltd. has announced the founding of Datum Orthobiologics Ltd. Datum Orthobiologics will foc... Devices, Orthopaedic, Regenerative Medicine Datum Biotech, Datum Orthobiologics, bone graft, GLYMATRIX (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news

Infected tooth with sinus perforation treatment: feedback?
A middle aged woman presented with a swollen gingiva buccal to tooth #15 which had a previous RCT and crown. I am wondering if I should place a membrane and bone graft after extracting the tooth or if I should let it drain on its own?The postInfected tooth with sinus perforation treatment: feedback? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - April 17, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Cases Regenerative Surgical Source Type: news

Spineology touts 1-year OptiMesh lumbar interbody fusion study results
Spinal tech developer Spineology today released 12-month results from a study of its OptiMesh deployable implant designed for use in instrumented lumbar interbody fusion procedures to treat degenerative disc disease. Results from the Scout trial were presented at the annual meeting of the International Society for the Advancement of Spine Surgery in Toronto, the St. Paul, Minn.-based company said. “We are grateful to Dr. Chi and all the Scout investigators for their dedication in helping us to complete this important clinical trial. We look forward to completing the patient follow-up and gaining the market ...
Source: Mass Device - April 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Spinal Spineology Source Type: news

Sinus Tract Next to Tenting Screw After Bone Graft and Implant Placement: How to Resolve?
After 5 months of uneventful healing of implants, I now see a small lesion resembling a sinus tract that is present in the immediate vicinity of one tenting screw.The postSinus Tract Next to Tenting Screw After Bone Graft and Implant Placement: How to Resolve? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - April 11, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Surgical Source Type: news

Ridge Augmentation: Thoughts about Bond Apatite synthetic Bone Graft?
Any thoughts on using synthetic bone augmentation materials, like Bond Apatite for lateral ridge augmentation or ridge widening?The postRidge Augmentation: Thoughts about Bond Apatite synthetic Bone Graft? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - April 6, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Regenerative Source Type: news

7 medtech stories we missed this week: March 23, 2018
[Image from unsplash.com]From Medizone’s evaluation deal to Advantis Medical Imaging getting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Medizone inks AsepticSure evaluation deal with commercial cleaning products maker Innovasource Medizone announced in a March 22 press release that it has signed a product evaluation agreement with Innovasource. As part of the agreement, Innovasource will be leading the evaluation of the AsepticSure system and compare it to existing cleaning practices in a number of facilities and settings. AsepticSure is desig...
Source: Mass Device - March 23, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Food & Drug Administration (FDA) Hospital Care Imaging Implants Patient Monitoring Regulatory/Compliance Respiratory advantismedicalimaging aziyobiologics Balt endospan Medizone MedTech Olympus Respiratory Motion Source Type: news

LifeNet Health launches unique, life-saving vascular allograft
AngioGraft® Aortoiliac Artery, the first to offer pressurized sizing, offers unparalleled efficiency and precision in aortic reconstruction VIRGINIA BEACH, Va., March 19, 2018 -- (Healthcare Sales & Marketing Network) -- LifeNet Health today announc... Devices, Cardiology, Surgery, Product Launch LifeNet Health, AngioGraft, Aortoiliac Artery, vascular allograft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2018 Category: Pharmaceuticals Source Type: news

Cerapedics wins FDA IDE nod for P-15L bone graft trial
Cerapedics said today it won FDA investigational device exemption approval to launch a clinical trial examining the safety and efficacy of its P-15L Peptide Enhanced bone graft. In the trial, the Wesminster, Colo.-based company will explore the use of the P-15L graft as it compares to autografts in transforaminal lumbar interbody fusion procedures meant for treating degenerative disk disease. “Prior research of this proprietary P-15 technology has demonstrated potential benefits in fusion rates, neurological outcomes and safety in cervical and lumbar fusions. We are pleased to participate in a new study evaluati...
Source: Mass Device - March 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Regulatory/Compliance Spinal Cerapedics Inc. Source Type: news

Cerapedics Receives FDA IDE Approval to Initiate Study of P-15L Bone Graft for Transforaminal Lumbar Interbody Fusion Surgery
Pivotal study to evaluate next-generation synthetic small peptide technology (P-15) compared to autograft in most common spine procedure WESTMINSTER, Colo., March 14, 2018 -- (Healthcare Sales & Marketing Network) -- Cerapedics, a privately-held orthob... Devices, Orthopaedic, FDA Cerapedics, orthobiologic, i-FACTOR, Peptide Enhanced Bone Graft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 14, 2018 Category: Pharmaceuticals Source Type: news

Autogenous Bone: Most Effective Material?
Two recent studies show good results with autogenous bone grafts, long considered the most effective material in bone regeneration procedures.The postAutogenous Bone: Most Effective Material? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - March 13, 2018 Category: Dentistry Authors: osseonews Tags: Implant News Surgical Source Type: news

Osteochondral allograft transplantation effective for certain knee cartilage repairs
(American Orthopaedic Society for Sports Medicine) Isolated femoral condyle lesions account for 75 percent of the cartilage repair procedures performed in the knee joint, and physicians have a variety of techniques to consider as part of surgical treatment. Osteochondral allograft transplantation (OCA) is a valuable and successful approach for this condition, as described by research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day in New Orleans. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 10, 2018 Category: International Medicine & Public Health Source Type: news

Medtronic wins one lawsuit, settles state AG probes over Infuse
Medtronic (NYSE:MDT) said a shareholder lawsuit brought over its Infuse bone-growth protein is over, after the U.S. Supreme Court declined to review the case. Approved in 2002 for use in spinal fusion surgery, Infuse at one point had annual sales of nearly $1 billion. The bone-grafting product has since been linked to abnormal bone growth, certain cancers and male reproductive problems. Fridley, Minn.-based Medtronic has been accused of not only downplaying the product’s risks but also promoting it for off-label use. The derivative lawsuit, brought in March 2012 by  investor Charlotte Kokocinski in the U.S. Dist...
Source: Mass Device - March 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Legal News Orthopedics Regenerative Medicine Medtronic Source Type: news

Human bone tissue grown from a patient's fat cells in a lab, then implanted to finish growing inside the patient's body
(Natural News) Thanks to an extraordinary medical procedure, a man is on the road to recovering from a fractured tibia with a bone graft created from his own fat cells. This isn’t a work of science fiction; it’s the result of efforts made by Bonus BioGroup, an Israel-based biomedical company. According to the TimesOfIsrael.com, a... (Source: NaturalNews.com)
Source: NaturalNews.com - March 4, 2018 Category: Consumer Health News Source Type: news

Collaboration Is Key in Bioventus ’s Path Toward Innovation
Durham, NC-based Bioventus is hoping to expand its position in the allograft market through a collaboration with LifeLink Foundation. The accord will have the companies work together to co-develop a next-generation bone allograft solution for use in spine and trauma surgery. Bivoentus specializes in orthobiologic products for bone healing, bone graft, and knee osteoarthritis. “LifeLink is a fully equipped tissue bank,” Samson Tom, vice president of research and development at Bioventus, told MD+DI. “Here at Bioventus, we have significant infrastructure, but we are not a tissue bank. We recognize partneri...
Source: MDDI - February 27, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Purulent discharge and radiolucent area around implant: Advice?
I placed an implant at area 32 with bone graft.  Saw patient after 18 days and there is purulent discharge and a radiolucent area around the implant.  (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - February 19, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Cases Surgical Source Type: news

Distal tibial allograft reconstruction and Latarjet may offer similar outcomes for recurrent anterior shoulder instability
According to a study published online in The American Journal of Sports Medicine, fresh distal tibia allograft (DTA) reconstruction and the Latarjet procedure may offer similar outcomes for recurrent anterior shoulder instability.  (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - February 10, 2018 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news

Detecting and treating dnDSA early preserves allograft function
(Children's National Health System) Monitoring and treating de novo donor-specific antibodies before they could cause graft damage helped to decrease dnDSA in a majority of pediatric kidney transplant recipients at Children National Health System and prevented graft failure in the first few years. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 5, 2018 Category: International Medicine & Public Health Source Type: news

Finland ’ s BBS-Bioactive Bone Substitute plans $10m IPO
BBS-Bioactive Bone Substitutes said today that’s its planning for an initial public offering later this year it hopes will bring in some $10 million. Oulu, Finland-based BBS said it plans to list 1.5 million shares at €5.50 apiece beginning Feb. 5 for gross proceeds of €7.7 million, or roughly $9.6 million. The shares, due to trade on the First North Finland and NASDAQ First North Sweden exchanges, would represent about 23.9% of BBS’s total shares if the flotation is fully subscribed. Based on proteins extracted from reindeer bone, BBS’s Artebone is designed to be injected to the site ...
Source: Mass Device - January 31, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Orthopedics Regenerative Medicine Wall Street Beat bioactivebonesolutions Source Type: news

Socket grafting after extraction of an infected endodontic tooth?
How do you treat and clean the socket after extraction of an infected endodontic tooth and prepare it for the bone graft for ridge preservation? (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - January 30, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Cases Clinical Questions Source Type: news

The University City Science Center is backing development of NJIT's novel bone graft tech
(New Jersey Institute of Technology) Treena Arinzeh, director of NJIT's Tissue Engineering and Applied Biomaterials Laboratory, has been awarded a grant from the University City Science Center in Philadelphia to help commercialize technology she is developing to reduce the recovery time and cost associated with bone grafts. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2018 Category: International Medicine & Public Health Source Type: news

West Sacramento-based bone graft company raises funds, wins federal clearance
Molecular Matrix Inc. has raised money and passed a major regulatory milestone for its product that helps bone heal. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 19, 2018 Category: Health Management Authors: Mark Anderson Source Type: news

West Sacramento-based bone graft company raises funds, wins federal clearance
Molecular Matrix Inc. has raised money and passed a major regulatory milestone for its product that helps bone heal. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 19, 2018 Category: Biotechnology Authors: Mark Anderson Source Type: news

New Kleiner Spine Graft Delivery Tool Improves Outcomes for Patients, Surgeons, Hospitals and Payers
DENVER, Jan. 10, 2018 -- (Healthcare Sales & Marketing Network) -- Kleiner Device Labs today announced full commercial availability of a new spinal bone graft delivery tool, the KG® 1, featuring a patented design that facilitates less-invasive procedu... Devices, Oncology, Neurosurgery, Product Launch Kleiner Device Labs, bone graft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2018 Category: Pharmaceuticals Source Type: news

Do I have to place a membrane in this immediate implant case?
I placed an implant in the maxillary lateral incisor site immediately after extraction and did a small particulate bone graft. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - January 5, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Surgical Source Type: news

RTI Surgical buys Zyga Tech and its SImmetry sacroiliac fusion device, updates 2018 outlook
RTI Surgical (NSDQ:RTIX) yesterday announced an agreement to purchase Zyga Technology and its SImmetry sacroiliac joint fusion system and today released updated guidance for 2018 and beyond. The Alachua, Fla.-based RTI surgical said that Zyga Technology has approximately 30 employees and $4 million in annual revenue, and that it plans to fund the acquisition through a combination of cash and through borrowing under its existing credit facility. Terms of the deal were not disclosed, and RTI Surgical it expects the deal to close when the Delaware Department of State re-opens as it is currently closed due to incleme...
Source: Mass Device - January 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Spinal RTI Surgical Source Type: news

NuVasive wins expanded FDA nod, launches interbody fusion devices
NuVasive Inc. (NSDQ:NUVA) said today it won expanded FDA 510(k) clearance for its Cohere cervical interbody fusion device and that it launched the Coalesce thoracolumbar interbody fusion device. Both the launch and updated clearance comes from the company’s acquisition of Vertera Spine, which it closed last September. The Cohere and Coalesce implants use porous version of the material polyetheretherketone, or PEEK, and are designed to provide three-dimensional achitecture to elicit and encourage bone growth, San Diego, Calif.-based NuVasive said. “Our strategy in building our AMS portfolio is to ...
Source: Mass Device - January 4, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Business/Financial News Food & Drug Administration (FDA) Regulatory/Compliance Spinal Nuvasive Source Type: news

Distants between implants considerable: long-term success?
I placed 2 implants in the maxillary right posterior quadrant using an indirect sinus lift without bone grafts.  I am concerned about a few issues. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - January 2, 2018 Category: Dentistry Authors: gkaplowitz Tags: Clinical Cases Surgical Source Type: news

Anika Therapeutics wins FDA nod for bone void filler
Anika Therapeutics (NSDQ:ANIK) said today that it won 510(k) clearance from the FDA for its hyaluronic acid-based bone void filler The indication covers filling bone voids or defects that aren’t intrinsic to the stability of the bone, created during surgery or the result of traumatic injury. Made of a synthetic, biocompatible bone graft substitute material, the filler is injected into a void and hardens at body temperature. It’s then resorbed and replaced by new bone growth. Get the full story at our sister site, Drug Delivery Business News. The post Anika Therapeutics wins FDA nod for bone void filler appeared...
Source: Mass Device - December 27, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Orthopedics Regulatory/Compliance Anika Therapeutics Inc. Source Type: news

Flapless procedure with no graft: Failing or Not?
I placed an immediate 3.5x13 Nobel Replace conical connection implant in area #7 using a flapless procedure with gap space about 1mm to 1.5, which was impossible to fill with bone graft. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - December 18, 2017 Category: Dentistry Authors: osseonews Tags: Clinical Cases Surgical Source Type: news

Knee Stability and Alterations in Synovial Fluid After Arthroscopic ACL Reconstruction With Hamstring Autograft or Hamstring Allograft
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - December 17, 2017 Category: Orthopaedics Tags: CME Article Source Type: news

Dehydrated Amniotic Membrane Allograft for Extremity Wounds Dehydrated Amniotic Membrane Allograft for Extremity Wounds
What benefits might this novel amniotic allograft offer in the treatment of lower extremity wounds?Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 15, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Medtronic Settles States' Probe Into Infuse Marketing for $12 Million Medtronic Settles States' Probe Into Infuse Marketing for $12 Million
Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 14, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Medtronic Forks Over $12 Million in Deceptive Marketing Settlement
Medtronic has agreed to pay a total of $12 million in a five-state settlement of litigation over its controversial Infuse bone graft device. Oregon Attorney General Ellen Rosenblum announced the settlement with Medtronic Sofamor Danek Inc. and Medtronic Sofamor Danek USA Inc. to resolve allegations that the company unlawfully promoted Infuse, used in spinal fusion procedures, to doctors. Other states participating in the settlement are California, Illinois, Massachusetts, and Washington. Oregon alleged that Medtronic made deceptive claims about Infuse by using trusted scientific publications to rep...
Source: MDDI - December 14, 2017 Category: Medical Devices Authors: Nancy Crotti Tags: Regulatory and Compliance Medical Device Business Source Type: news

Sintered Xenograft over Allograft?
There is an article which describes using sintered xenograft (bovine) over an allograft for Ridge Augmentation. Any thoughts on this technique? (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - December 14, 2017 Category: Dentistry Authors: osseonews Tags: Clinical Questions Regenerative Source Type: news

Medtronic to pay $12m to settle Infuse false marketing claims
Medtronic‘s (NYSE:MDT) spinal devices division has agreed to pay $12 million to settle allegations that the medtech giant made false claims to doctors and patients about its Infuse bone-growth protein, according to a Star Tribune report. States joining in the settlement include California, Massachusetts, Illinois, Washington and Oregon, according to the report. In Oregon, Attorney General Ellen Rosenblum said that Medtronic Sofamor Danek agreed to settle claims that it manipulated journal articles to make its controversial Infuse protein appear safer than it was to sell more products, breaking Oregon law, the Star Tr...
Source: Mass Device - December 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Legal News Spinal Medtronic Source Type: news

Medtronic settles states' probe into Infuse marketing for $12 million
BOSTON (Reuters) - Medtronic Plc has agreed to pay $12 million to resolve claims that the company engaged in a deceptive marketing strategy to promote its Infuse bone graft product used in spinal surgery, the Massachusetts attorney general said on Wednesday. (Source: Reuters: Health)
Source: Reuters: Health - December 13, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis
Bone destruction is a hallmark of myeloma and affects 80% of patients. Myeloma cells promote bone destruction by activating osteoclasts. In investigating the underlying mechanism, we found that C-reactive protein (CRP), a protein secreted in increased amounts by hepatocytes in response to myeloma-derived cytokines, activated myeloma cells to promote osteoclastogenesis and bone destruction in vivo. In mice bearing human bone grafts and injected with multiple myeloma cells, CRP bound to surface CD32 (also known as FcRII) on myeloma cells, which activated a pathway mediated by the kinase p38 MAPK and the transcription factor ...
Source: Signal Transduction Knowledge Environment - December 12, 2017 Category: Science Authors: Yang, J., Liu, Z., Liu, H., He, J., Yang, J., Lin, P., Wang, Q., Du, J., Ma, W., Yin, Z., Davis, E., Orlowski, R. Z., Hou, J., Yi, Q. Tags: STKE Research Articles Source Type: news

State of the U.S. Market for Dental Bone Graft Substitutes and Other Biomaterials
The dental bone graft substitute and other biomaterials market includes dental bone graft substitutes (DBGS), dental growth factors, and dental barrier membranes. The DBGS market is relatively stable with an increasing shift towards allografts. Already representing the largest segment of total DBGS materials, the allograft market is expected to grow at a 5.8% compound annual growth rate (CAGR) by 2023. The most innovative market in dental biomaterials is dental growth factor technology. However, these products have been slow to make strides on the market due to their relatively high price point. As such, growth within the ...
Source: MDDI - December 9, 2017 Category: Medical Devices Authors: Salma Mashkoor and Celine Mashkoor Tags: Materials Source Type: news

Bone Resorption During Submerged Healing After Guided Bone Regeneration: A Prospective Case Series
Conclusion: Loss in graft quantity was observed after ridge augmentation using an allograft and nonresorbable membrane during submerged healing before implant placement. Further studies with larger sample sizes are recommended to confirm its findings. (Source: Dental Technology Blog)
Source: Dental Technology Blog - December 4, 2017 Category: Dentistry Source Type: news

Spinal Elements lifts former COO Blain to the corner office | Personnel Moves November 30, 2017
Spinal Elements, previously known as Amendia, said this week it is lifting co-founder and current prez & COO Jason Blain to the position of prez & CEO, effective immediately. Prior to coming on to co-found Spinal Elements, Blain served in various roles with medtech companies Smith & Nephew (NYSE:SNN), Alphatec (NSDQ:ATEC) and NuVasive Inc. (NSDQ:NUVA). Blain is replacing Chris Fair, who will stay on as a board member with the company. “I am excited by the opportunity to lead our talented team of employees and partners and create an even more vibrant and dynamic Spinal Elements in the years ...
Source: Mass Device - November 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Abbott Alphatec Apica Cardiovascular Bovie Medical Corp. Cardiovascular Systems Inc. Dentsply Sirona Guidant Corp. Lima Corporate Medical Device Innovation Consortium MedLumics MedTech Europe Medtronic Nuv Source Type: news

MiMedx Provides Update On Its Reimbursement Coverage
MARIETTA, Ga., Nov. 21, 2017 -- (Healthcare Sales & Marketing Network) -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts ... Regenerative Medicine, Reimbursement MiMedx, EpiFix, Venous Leg Ulcer, Diabetic Foot Ulcer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 21, 2017 Category: Pharmaceuticals Source Type: news

RTI Surgical reveals FDA warning letter over Map3 allograft classification
RTI Surgical (NSDQ:RTIX) today revealed a warning letter it received from the FDA related to processes used to manufacture its Map3 cellular allogeneic bone graft over issues with the regulatory classification of the product. The Alachua, Fla.-based company said it received the letter on November 9 based on an inspection of its facilities from April and that it is preparing an appropriate response to the letter. In the letter, the FDA asserted that the Map3 allograft could not be regulated solely as a human cell, tissue and cellular and tissue-based product, but that the product was also subject to regulations applica...
Source: Mass Device - November 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regenerative Medicine RTI Surgical Source Type: news

Hologic to retain CEO MacMillan | Personnel Moves – November 3, 2017
Hologic (NSDQ:HOLX) said this week its current prez and CEO Stephen MacMillan will stay on with the company, resolving rumors that he may depart it to take up the corner office at Zimmer Biomet (NYSE:ZBH). In an SEC filing, the Marlborough, Mass.-based company’s board said it approved a special “performance-based retention equity grant” to MacMillan after he had begun to receive interest from other medical device firms. “Mr. MacMillan has led a dramatic turnaround of Hologic since joining in December 2013. The company’s performance has increased significantly under his...
Source: Mass Device - November 3, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News ConMed Corp. Hologic Invacare kentimaging Meritech Capital Partners Pulmatrix Inc. Sanofi-Aventis Smith & Nephew Tissue Regenix zimmerbiomet Source Type: news

Wright Medical shares tumble on Q3 sales miss, growing losses
Shares in Wright Medical (NSDQ:WMGI) fell today after the medical device maker missed sales expectations on Wall Street with its 3rd quarter earnings results. The Netherlands-based company posted losses of $131.9 million, or $1.26 per share, on sales of $170.5 million for the 3 months ended September 30, seeing losses grow 19.7% while sales grew a smaller 8.4% compared with the same period last year. Adjusted to exclude 1-time items, losses per share were 16¢, just ahead of the 17¢ consensus on Wall Street, where analysts expected to see revenue of $173.6 million. “Our U.S. upper extremities business h...
Source: Mass Device - November 2, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup wrightmedical Source Type: news

MiMedx Agrees To Lawsuit Settlement With Halo Wound Solutions
MARIETTA, Ga., Nov. 1, 2017 -- (Healthcare Sales & Marketing Network) -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts a... Devices, Regenerative Medicine, Wound Care, Litigation MiMedx, Halo Wound Solutions (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 1, 2017 Category: Pharmaceuticals Source Type: news

Arthrosurface acquires allograft tech from Wasas
Arthrosurface said today that it paid an unspecified amount to acquire an acellular dermal stabilization device technology from Wasas LLC. Derived from human tissue, acellular dermis is made using a process that removes cells but retains portions of the extracellular matrix to create dermal allografts. The deal includes the patent rights for the technology, which Franklin, Mass.-based Arthrosurface plans to develop and market “a platform of novel methods to be used to correct orthopedic challenges” for several indications. Wasas is based in Ft. Lauderdale. “The availability of this allograf...
Source: Mass Device - October 30, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Orthopedics Wall Street Beat Arthrosurface wasas Source Type: news

NASS 2017 Roundup: Zimmer Biomet launches Vitality+, Vital spinal fixation systems
Zimmer Biomet (NYSE:ZBH) today announced the launch of its Vitality+ and Vital spine fixation systems in the US following recent 510(k) clearance for pedicle preparation and screw insertion under power. The Vitality+ spinal fixation system is composed of a Vitality+ Power designed for controlled pedicle preparation and pedicle screw insertion, Vitality+ PSO designed for optimal pedicle subtraction osteotomy and vertebral column resection and Vitality+ Hooks for additional fixation options, the Warsaw, Ind.-based company said. The recent clearance allows the inclusion of the market’s first flexible drill and blun...
Source: Mass Device - October 25, 2017 Category: Medical Devices Authors: Fink Densford Tags: Spinal depuysynthes gssolutions johnsonandjohnson LifeNet Health Misonix Mizuho OSI Nuvasive RTI Surgical Xtant Medical zimmerbiomet Source Type: news

LifeNet Health Provides Uncompromised Fusion Solution with Launch of PliaFX(R) Strip
Presentations at NASS Annual Meeting (Booth 1113) will highlight the technology behind PliaFX Strip ORLANDO, Fla., Oct. 25, 2017 -- (Healthcare Sales & Marketing Network) -- LifeNet Health has introduced its latest allograft bone-healing solution, the ... Devices, Orthopaedic, Product Launch LifeNet Health, PliaFX, allograft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 25, 2017 Category: Pharmaceuticals Source Type: news

TGF-{beta} receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis
Signaling by the transforming growth factor–β (TGF-β) receptors I and II (TβRI/II) and the primary cilia-localized sonic hedgehog (Shh) pathway promote cell migration and, consequently, tumor metastasis. In contrast, the sphingolipid ceramide inhibits cell proliferation and tumor metastasis. We investigated whether ceramide metabolism inhibited TβRI/II trafficking to primary cilia to attenuate cross-talk between TβRI/II and the Shh pathway. We found that ceramide synthase 4 (CerS4)–generated ceramide stabilized the association between TβRI and the inhibitory factor Smad7, which lim...
Source: Signal Transduction Knowledge Environment - October 24, 2017 Category: Science Authors: Gencer, S., Oleinik, N., Kim, J., Panneer Selvam, S., De Palma, R., Dany, M., Nganga, R., Thomas, R. J., Senkal, C. E., Howe, P. H., Ogretmen, B. Tags: STKE Research Articles Source Type: news

R3 Stem Cell Now Offering Amniotic Membrane Allograft for Effective...
Regenerative medicine company R3 Stem Cell is now offering amniotic membrane allograft for eye care treatment. The membranes are safe, effective, FDA regulated and excellent for all types of...(PRWeb October 23, 2017)Read the full story at http://www.prweb.com/releases/amnioticmembraneallograft/r3-stem-cell/prweb14831115.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 23, 2017 Category: Pharmaceuticals Source Type: news